Pages that link to "Q30360002"
Jump to navigation
Jump to search
The following pages link to Protection from lethal influenza virus challenge by oral type 1 interferon. (Q30360002):
Displaying 35 items.
- Agonists of proteinase-activated receptor-2 enhance IFN-gamma-inducible effects on human monocytes: role in influenza A infection (Q24309213) (← links)
- Disease-promoting effects of type I interferons in viral, bacterial, and coinfections (Q28082841) (← links)
- Effect of sublingual administration of interferon-alpha on the immune response to influenza vaccination in institutionalized elderly individuals (Q28286173) (← links)
- Heterogeneous pathological outcomes after experimental pH1N1 influenza infection in ferrets correlate with viral replication and host immune responses in the lung. (Q30366138) (← links)
- Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding (Q30374356) (← links)
- Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets (Q30374748) (← links)
- Pandemic influenza vaccines. (Q30380902) (← links)
- Transmission of pandemic H1N1 influenza virus and impact of prior exposure to seasonal strains or interferon treatment. (Q30381638) (← links)
- Pandemic influenza A (H1N1) virus infection and avian influenza A (H5N1) virus infection: a comparative analysis (Q30391696) (← links)
- Influenza A virus transmission: contributing factors and clinical implications (Q30397203) (← links)
- Low-Dose Interferon Type I Treatment Is Effective Against H5N1 and Swine-Origin H1N1 Influenza A VirusesIn VitroandIn Vivo (Q30399720) (← links)
- Antiviral Potential of Exogenous Human Omega Interferon to Inhibit Pandemic 2009 A (H1N1) Influenza Virus (Q30408266) (← links)
- Low-dose oral interferon alpha as prophylaxis against viral respiratory illness: a double-blind, parallel controlled trial during an influenza pandemic year (Q30427052) (← links)
- Innate immune evasion strategies of influenza viruses (Q33646273) (← links)
- Pathogenic potential of interferon αβ in acute influenza infection (Q33663298) (← links)
- Oromucosal Administration of Interferon to Humans (Q33663987) (← links)
- Partial depletion of natural CD4⁺CD25⁺ regulatory T cells with anti-CD25 antibody does not alter the course of acute influenza A virus infection (Q34085796) (← links)
- A novel broad-spectrum treatment for respiratory virus infections: Influenza-based defective interfering virus provides protection against pneumovirus infection in vivo (Q34164497) (← links)
- Biodegradable nanogels for oral delivery of interferon for norovirus infection (Q34525191) (← links)
- Pharmacologic activation of the innate immune system to prevent respiratory viral infections (Q35692082) (← links)
- Involvement of the different lung compartments in the pathogenesis of pH1N1 influenza virus infection in ferrets (Q36186133) (← links)
- Intranasal Administration of Chitosan Against Influenza A (H7N9) Virus Infection in a Mouse Model (Q37049832) (← links)
- Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge (Q37455765) (← links)
- Innate immune protection against infectious diseases by pulmonary administration of a phospholipid-conjugated TLR7 ligand (Q37678709) (← links)
- Oral delivery of oligomeric procyanidins in Apple Poly® enhances type I IFN responses in vivo (Q37700175) (← links)
- Type I Interferon Modulates the Battle of Host Immune System Against Viruses (Q37783734) (← links)
- What role (if any) does the highly conserved CSB-PGBD3 fusion protein play in Cockayne syndrome? (Q38078156) (← links)
- Generation and characterization of interferon-lambda 1-resistant H1N1 influenza A viruses. (Q38696286) (← links)
- The Impact of the Interferon/TNF-Related Apoptosis-Inducing Ligand Signaling Axis on Disease Progression in Respiratory Viral Infection and Beyond (Q39223220) (← links)
- The microbial metabolite desaminotyrosine protects from influenza through type I interferon. (Q40107499) (← links)
- Advancements in Host-Based Interventions for Influenza Treatment (Q56996774) (← links)
- Treating Influenza Infection, From Now and Into the Future (Q57158941) (← links)
- Low-dose interferon-α treatment improves survival and inflammatory responses in a mouse model of fulminant acute respiratory distress syndrome (Q86113227) (← links)
- Single-Cell Virus Sequencing of Influenza Infections That Trigger Innate Immunity (Q91862858) (← links)
- Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections (Q92404820) (← links)